Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

PFIZER INC.

Filed by TODD STRATEGY GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Mar 17, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
ab74248d-1dcf-49d1-b312-a9d4027c1459
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Issues related to FDA regulation of pharmaceuticals. H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Vaccine Policy, Coverage and Access and the Vaccine Injury Compensation Fund. H.R.2214 - DRUG Act. S.832 - EPIC Act of 2025.

Literal federal measure citations: H.R.1492, H.R.2214, S.832

TAR · Tariff (miscellaneous tariff bills)

Issues related to tariff and trade policy. International Supply Chain.

TRD · Trade (domestic/foreign)

Issues related to tariff and trade policy.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.